In a 36-year-old gravida 4 para 3 woman with asthma, gestational diabetes, and polyhydramnios who develops postpartum hemorrhage with hypotension, tachycardia, and a boggy uterus, which uterotonic agent is contraindicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methylergonovine is Contraindicated in This Patient

Methylergonovine (and all ergot alkaloids) must be avoided in this patient with asthma because it causes bronchospasm and can precipitate severe respiratory distress. 1, 2

Clinical Reasoning

This patient presents with classic postpartum hemorrhage (PPH) due to uterine atony—evidenced by hypotension (80/50 mm Hg), tachycardia (120 bpm), and a boggy uterus after delivery. 2 While multiple uterotonic agents are available for treatment, her history of asthma is the critical contraindication that eliminates methylergonovine as an option.

Why Methylergonovine is Contraindicated

  • Ergometrine (methylergonovine) should be avoided entirely in women with respiratory diseases as it may cause bronchospasm. 1, 3
  • Ergot alkaloids are absolutely contraindicated in patients with asthma or any reactive airway disease due to their bronchoconstriction effects. 1
  • The European Respiratory Society explicitly warns against ergometrine use in women with respiratory conditions. 1

Why the Other Agents Are NOT Contraindicated

Oxytocin

  • Oxytocin is the uterotonic of choice for women with respiratory diseases and should be the first-line agent in this patient. 1, 4
  • It has no bronchoconstrictive effects and is safe in asthma. 1
  • Administer 5-10 IU via slow IV infusion (over 1-2 minutes) or 10 IU intramuscularly. 1

Misoprostol

  • Misoprostol (a PGE1 analog) does not cause significant bronchospasm and can be used in asthmatic patients. 5, 6
  • While less effective than other second-line agents, it remains a viable option when other uterotonics are contraindicated. 7, 5

Carboprost

  • This requires careful consideration. Carboprost is a prostaglandin F2α analog that can cause bronchoconstriction and is not recommended in women with asthma. 1, 6
  • However, the question asks which agent is contraindicated, and the evidence more strongly and consistently identifies ergot alkaloids as absolutely contraindicated in asthma. 1
  • Carboprost carries a warning but may be used with extreme caution if other options fail, whereas methylergonovine should never be used. 1, 2

Treatment Algorithm for This Patient

  1. First-line: Administer oxytocin 5-10 IU slow IV (over 1-2 minutes) or 10 IU IM immediately. 1, 2

  2. If atony persists: Consider misoprostol 800-1000 mcg rectally as the safest second-line option given her asthma. 5, 6

  3. Avoid completely: Methylergonovine due to bronchospasm risk. 1

  4. Use with extreme caution only if necessary: Carboprost, but only after weighing risks versus benefits and with respiratory support available. 1, 6

  5. Adjunctive therapy: Administer tranexamic acid 1g IV if not already given, as this patient has established PPH. 1

Common Pitfalls

  • Do not assume all second-line uterotonics are interchangeable—patient comorbidities (especially asthma, hypertension, and cardiovascular disease) dictate which agents are safe. 2, 8
  • Do not delay second-line uterotonic administration if oxytocin fails to restore tone—early escalation improves outcomes. 2, 8
  • Do not give oxytocin as a rapid IV bolus—this causes hypotension and tachycardia, which would worsen this patient's already compromised hemodynamics. 1, 4

References

Guideline

Management of the Third Stage of Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Refractory uterine atony: still a problem after all these years.

International journal of obstetric anesthesia, 2021

Guideline

Respiratory Mechanics During Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oxytocin Administration in Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Update on the use of uterotonic agents].

Revista espanola de anestesiologia y reanimacion, 2012

Research

Optimal uterotonic management.

Best practice & research. Clinical anaesthesiology, 2022

Related Questions

What are the World Health Organization (WHO) guidelines for managing postpartum hemorrhage (PPH)?
What is the diagnosis for a 39-year-old primigravida (first pregnancy) at 38 weeks gestation with a history of hypertension treated with nifedipine (calcium channel blocker) and asthma treated with albuterol (beta-2 adrenergic receptor agonist), who develops postpartum hemorrhage (PPH) with a soft uterus after a forceps-assisted vaginal delivery and manual placental extraction?
What is the cause of profuse vaginal bleeding in a 27-year-old woman, gravida 2 para 1, at 40 weeks gestation, with a history of preeclampsia with severe features, who underwent a forceps-assisted vaginal delivery and has a firm, nontender uterus with a right vaginal sidewall defect?
What is the most appropriate next step in managing a patient with a densely adherent placenta to the anterior uterine wall after a repeat cesarean delivery (C-section)?
What medication should be avoided in a postpartum patient with chronic hypertension (high blood pressure), tachycardia, and profuse vaginal bleeding due to a soft uterine fundus and distended lower uterine segment with blood clots, who is being managed with labetalol (labetalol)?
What dose of dexamethasone is recommended for an adult patient with a peritonsillar abscess?
What is the most appropriate initial antimicrobial therapy for a 45-year-old man with human immunodeficiency virus infection, diabetes mellitus, chronic kidney disease on intermittent hemodialysis presenting with acute bacterial parotitis of the left parotid gland?
What is the composition, dosing regimen, and contraindications of hepatic drops (standardized milk‑thistle extract) for an adult patient (≥12 years) requiring hepatic support?
What is the recommended IV fluid regimen (type, rate, monitoring, and albumin use) for an adult (≥12 years) with acute viral hepatitis or decompensated chronic hepatitis, especially when ascites, hepatic encephalopathy, or pulmonary congestion are present?
What is the next indicated intervention for a stable 16‑year‑old female presenting with acute nausea, vomiting, mild generalized abdominal pain, benign abdominal examination, normal laboratory studies, and a history of frequent hot showers?
What organism most likely infected this 30‑year‑old woman who returned from the Dominican Republic with a diffuse maculopapular rash, headache, fever, conjunctivitis, and viral RNA detected in serum, and who was advised to avoid unprotected intercourse for at least two months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.